Sat, Jul 5th, 2025
  • facebook
  • twitter
  • youtube
  • instagram
  • HOME
  • BUSINESS
  • POLITICS
  • ECONOMY
  • COUNTRIES
    • Caucasus
      • Armenia
      • Azerbaijan
      • Georgia
    • Central Asia
      • Kazakhstan
      • Kyrgyzstan
      • Tajikistan
      • Turkmenistan
      • Uzbekistan
    • Eastern Europe
      • Belarus
      • Moldova
      • Ukraine
    • Russia
  • OPINION
  • LIFESTYLE
  • FOCUS
The Tribune Logo
  • HOME
  • BUSINESS
  • POLITICS
  • ECONOMY
  • COUNTRIES
    • Caucasus
      • Armenia
      • Azerbaijan
      • Georgia
    • Central Asia
      • Kazakhstan
      • Kyrgyzstan
      • Tajikistan
      • Turkmenistan
      • Uzbekistan
    • Eastern Europe
      • Belarus
      • Moldova
      • Ukraine
    • Russia
  • OPINION
  • LIFESTYLE
  • FOCUS
Sat, Jul 5th, 2025
  • HOME
  • BUSINESS
  • POLITICS
  • ECONOMY
  • COUNTRIES
    • Caucasus
      • Armenia
      • Azerbaijan
      • Georgia
    • Central Asia
      • Kazakhstan
      • Kyrgyzstan
      • Tajikistan
      • Turkmenistan
      • Uzbekistan
    • Eastern Europe
      • Belarus
      • Moldova
      • Ukraine
    • Russia
  • OPINION
  • LIFESTYLE
  • FOCUS
  • HOME
  • BUSINESS
  • POLITICS
  • ECONOMY
  • COUNTRIES
    • Caucasus
      • Armenia
      • Azerbaijan
      • Georgia
    • Central Asia
      • Kazakhstan
      • Kyrgyzstan
      • Tajikistan
      • Turkmenistan
      • Uzbekistan
    • Eastern Europe
      • Belarus
      • Moldova
      • Ukraine
    • Russia
  • OPINION
  • LIFESTYLE
  • FOCUS
BUSINESS
- Uzbekistan
EBRD, Uzbekistan’s second-largest state bank to support local pharmaceutical producer
Tashkent, capital of Uzbekistan (Alamy)

TASHKENT

The European Bank for Reconstruction and Development (EBRD) and Uzbekistan’s second-largest lender, Uzpromstroybank, will provide new funds to support and strengthen a local pharmaceutical producer in order to meet growing market demand during the COVID-19 pandemic.

The EBRD will finance half of a 7.82 million loan euro provided by Uzpromstroybank to medical producer Samarkand England Eco-Medical (SEEM). This will be the first transaction under a 50:50 risk-sharing framework signed between the two banks, the EBRD said.

SEEM, which manufactures intravenous fluids such as sodium chloride, glucose and amino acids, will use the loan to expand its production facility and to start manufacturing generic and specialised medicines in tablets and capsules.

The financial support to SEEM, the second-largest producer of intravenous solutions in Uzbekistan, will increase the availability of affordable medical goods in Uzbekistan.

Uzpromstroybank operates a network of 45 branches and 170 outlets across the populous Central Asian country.

The project is in line with the EBRD’s strategy for Uzbekistan, aimed at enhancing the role of the private sector in the national economy. It will also help to reduce the reliance on foreign supplies in the country, where 75 percent of medical goods are imported.

To date, the EBRD has invested almost 2.6 billion euros in 101 projects in Uzbekistan.

Rated ‘BB-‘ by Fitch Ratings and S&P, Uzpromstroybank, also known as Uzsanoatqurilishbank, is among several state-owned banks due to be privatised under the government programme.

The EBRD said in June it would take part in the pre-privatisation process of Uzpromstroybank by providing a $50 million credit line and eventually become one of the bank’s shareholders.

Earlier this year, the EBRD also provided Uzpromstroybank with a $45 million loan to expand its Green Economy Financing Facility, launched in Uzbekistan in 2019, to support green finance for small private-sector companies investing in green technology solutions. The loan will also help the bank in lending to domestic small and medium-sized enterprises (SMEs) willing to invest in climate mitigation and adaptation technologies and services.

Oct 13, 2021

DATA SNAPSHOT

BANKS
- Azerbaijan
Fitch affirms Azerbaijan’s Expressbank at ‘B’, outlook Stable
TRADE
- Uzbekistan
Uzbekistan’s foreign trade turnover at $13.15 bln in Q1, 2022
ECONOMY
- Belarus
Belarus inflation up 15.9% yr/yr in March-Statistics Committee
ECONOMY
- Georgia
Remittances to Georgia rise 3% yr/yr to $193 mln in March-central bank
THE TRIBUNE
- Eurasia
The Tribune suspends publication
HEALTH
- Covid-19
COVID-19 Eurasia Roundup
The Tribune keeps you up-to-date with the latest vaccines and infection data across the region.
OPINION
- Kazakhstan
OPINION-Kazakhstan’s Reforms Should Be More Than Just Show-FOREIGNPOLICY
  • facebook
  • twitter
  • youtube
  • instagram
  • Privacy Policy
  • Cookie Policy
  • About Us
  • Contact Us
NEWSLETTER

I have read the privacy policy and consent to the storage of my data in your archive.

© 2021 thetribune.com All rights reserved.